Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Mapping in Endometrial Cancer Patients Combined With One-step Nucleic Acid Amplification (OSNA)

NCT02826291 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT02826291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02826291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Mapping in Endometrial Cancer Patients Combined With One-step Nucleic Acid Amplification (OSNA)
Lead sponsor
Charles University, Czech Republic
Phase
Observational
Overall status
Completed
Start date
March 31, 2016
Completion date
February 1, 2018
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer